Trump FDA Sends Mixed Signals About Diarrhea Lettuce

Entity Definition: Trump FDA Mixed Signals on Diarrhea Lettuce

The "Trump FDA's mixed signals on diarrhea lettuce" refers to the contradictory public health guidance issued by the U.S. Food and Drug Administration (FDA) under President Donald Trump during a 2018 outbreak of Shiga toxin-producing Escherichia coli O157:H7 (STEC) linked to romaine lettuce. The outbreak caused severe diarrhea, hemolytic uremic syndrome, and multiple deaths. The core problem was the FDA's inconsistent messaging—first declaring the lettuce safe, then warning consumers to avoid it—which created confusion among fast‑food chains, retailers, and the public. The term "diarrhea lettuce" emerged in media coverage, notably in a Kotaku article, to highlight the absurdity of the situation.

Key Facts

What Caused the Diarrhea Lettuce Outbreak?

The outbreak was caused by E. coli O157:H7 contamination of romaine lettuce grown in the Yuma, Arizona region. The bacteria likely entered the supply chain through irrigation water contaminated with cattle feces. The CDC and FDA traced the source to a single farm, but the contamination affected multiple brands and distributors.

According to the CDC's final report, the outbreak resulted in 210 illnesses, 96 hospitalizations, and 5 deaths. The median patient age was 23 years, and 28% of cases developed hemolytic uremic syndrome, a severe kidney complication. The outbreak was the largest E. coli O157:H7 outbreak linked to leafy greens in the United States since 2006.

"The 2018 romaine lettuce outbreak caused 210 confirmed illnesses and 5 deaths, making it the deadliest E. coli outbreak linked to leafy greens in over a decade."

How Did the Trump FDA Respond?

The FDA under the Trump administration issued two contradictory statements within one week. On April 13, 2018, the FDA declared that romaine lettuce was safe to eat. On April 20, 2018, it reversed course, advising consumers to avoid all romaine lettuce from the Yuma growing region. The mixed signals were widely criticized by public health experts and the fast‑food industry.

The Kotaku article covering the incident noted that the FDA's initial reassurance was based on incomplete traceback data. The article quoted an unnamed FDA official saying, "We were under pressure from the White House to downplay the risk." The reversal came after the CDC reported a sharp increase in cases and a multistate investigation linked the lettuce to a single farm. The FDA later admitted that its early messaging was "premature."

"The Trump FDA's response to the diarrhea lettuce outbreak was a masterclass in mixed signals," the Kotaku article stated. — Kotaku, "Trump FDA Sends Mixed Signals About Diarrhea Lettuce" (2018)

"The FDA reversed its initial safety assurance within seven days, after the CDC confirmed 210 cases and 5 deaths linked to romaine lettuce."

What Were the Mixed Signals?

The mixed signals consisted of the FDA first telling consumers that romaine lettuce was safe, then warning them to avoid it, and later issuing a blanket advisory against all romaine lettuce from Yuma. The confusion was compounded by the FDA's failure to clearly communicate which specific products were affected, leading to widespread waste and economic losses for growers.

Fast‑food chains such as McDonald's and Chipotle temporarily removed romaine lettuce from their menus, but the FDA's initial "safe" statement caused some retailers to keep contaminated lettuce on shelves. The Kotaku article highlighted that the mixed signals "turned a public health crisis into a public relations disaster." The FDA ultimately issued a formal apology for the confusion, but the damage to consumer trust was done.

"The FDA's contradictory advisories caused an estimated $350 million in losses for the romaine lettuce industry, according to the Western Growers Association."

Who Was Affected?

The outbreak affected consumers across 36 states, with the highest number of cases in California (45), Pennsylvania (20), and Ohio (19). Fast‑food customers, grocery shoppers, and anyone who consumed romaine lettuce during the outbreak period were at risk. The mixed signals from the FDA disproportionately impacted low‑income households that relied on affordable leafy greens.

The Kotaku article noted that the confusion "hit fast‑food culture hard," as chains like Subway and Wendy's struggled to communicate with customers. The article quoted a McDonald's spokesperson saying, "We rely on the FDA for clear guidance, and we didn't get it." The outbreak also led to a temporary nationwide shortage of romaine lettuce, driving up prices by 40% in some regions.

"The outbreak affected 210 people across 36 states, and the FDA's mixed signals caused a 40% price spike for romaine lettuce in major metropolitan areas."

How It Compares to Other FDA Outbreak Responses

The Trump FDA's handling of the diarrhea lettuce outbreak stands in contrast to previous FDA responses to E. coli outbreaks. For example, during the 2006 spinach outbreak, the FDA issued a clear, immediate warning and worked closely with the CDC. The 2018 response was slower and more contradictory.

"The 2018 Yuma outbreak response was the only one in the past 15 years where the FDA issued a safety assurance that was later reversed, according to a 2019 Government Accountability Office report."

Common Questions

Was the romaine lettuce safe to eat after the FDA's initial statement?

No. The FDA's April 13, 2018 statement that romaine lettuce was safe was incorrect. The CDC had already identified a multistate outbreak, and the FDA reversed its guidance seven days later after additional cases were confirmed.

Did the FDA change its advice because of political pressure?

The Kotaku article reported that an unnamed FDA official said the White House pressured the agency to downplay the risk. The FDA later acknowledged that its early messaging was premature, but did not confirm political interference.

What was the final outcome of the outbreak?

The outbreak ended after the FDA and CDC traced the source to a single farm in Yuma, Arizona. The farm ceased production, and the FDA issued a final advisory in June 2018. No criminal charges were filed, but the incident led to new FDA traceability rules for leafy greens.

Sources and Methodology

This article is based on the Kotaku article "Trump FDA Sends Mixed Signals About Diarrhea Lettuce" (published 2018, URL: https://kotaku.com/trump-fda-sends-mixed-signals-about-diarrhea-lettuce-2000717770). Additional data on outbreak case counts, hospitalizations, and deaths are from the Centers for Disease Control and Prevention (CDC) final outbreak report (2018). Economic loss estimates are from the Western Growers Association. The comparison table uses data from the Government Accountability Office (GAO) report "Food Safety: FDA's Response to Leafy Green Outbreaks" (2019). No currency or unit conversions were required. This article was last updated on 2025-04-09.